Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
WVE
WVE News & Events
-
Add to Watchlist
Trade WVE
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Forecast
Technical
Valuation
Financials
Earnings
Should I Buy
News
WVE News
Latest Wall Street Rating Updates
3 days ago
CNBC
Wave Life Sciences Regains Full Rights to WVE-006 from GSK
6 days ago
Benzinga
Wave Life Sciences Regains AATD Asset WVE-006 from GSK
6 days ago
seekingalpha
Wave Life Sciences Advances WVE-006 Therapeutic Program
6 days ago
Newsfilter
Eli Lilly and Novo Nordisk Drive Diversification in Obesity Drug Market
Jan 23 2026
CNBC
Wave Life Sciences (WVE) Director Exercises 42,000 Options, Sells for $630,000
Jan 14 2026
Fool
Wave Life Sciences Director Adrian Rawcliffe Sells 42,000 Shares for ~$630,000
Jan 14 2026
NASDAQ.COM
Anticipate a Hectic Year for Obesity Medications with New Pills Launching
Jan 12 2026
Barron's
Show More News
WVE Events
No data
WVE Monitor News
WAVE Life Sciences Ltd. declines amid obesity drug market diversification
Jan 28 2026
WAVE Life Sciences Ltd sees significant price increase amid positive analyst outlook
Jan 06 2026
WAVE Life Sciences Ltd experiences significant drop amid public offering announcement
Dec 11 2025
WAVE Life Sciences Ltd Announces $250 Million Public Offering
Dec 09 2025
WAVE Life Sciences Ltd reaches 20-day high ahead of WVE-007 trial data
Dec 08 2025
WVE Earnings Analysis
No Data
People Also Watch
